Approval · Notice of Compliance 28567 · 2022
VALCYTE: Notice of Compliance 28567
Issued July 11, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28567
- Date
- July 11, 2022
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
Medicinal ingredients
- VALGANCICLOVIR HYDROCHLORIDE 450 MG per TAB
- VALGANCICLOVIR HYDROCHLORIDE 50 MG per ML